Mark Jacobson | Chief Operating Officer |
Herriot Tabuteau | Chief Executive Officer |
Nick Pizzie | Chief Financial Officer |
Lori Englebert | Senior Vice President of Commercial and Business Development |
Amanda Jones | Senior Vice President, Clinical Development |
Charles Duncan | Cantor Fitzgerald |
Joon Lee | Truist Securities |
Vikram Purohit | Morgan Stanley |
Marc Goodman | SVB Leerink |
Vamil Divan | Mizuho Securities |
Joseph Thome | Cowen & Company |
Ram Selvaraju | H.C. Wainwright |
Jason Gerberry | Bank of America |
Yatin Suneja | Guggenheim |
Chris Howerton | Jefferies |
Matt Kaplan | Ladenburg Thalmann |
Bert Hazlett | BTIG |
Myles Minter | William Blair |
David Hoang | SMBC |
Esther Hong | Berenberg |
Good morning, and welcome to the Axsome Therapeutics Conference Call. Currently, all participants are in a listen-only mode. Later, there will be a question-and-answer session and instructions will follow at that time.
As a reminder, today's conference call is being recorded. I would now like to turn the conference over to your host, Mark Jacobson, Chief Operating Officer at Axsome Therapeutics.